Jacobson Mark L.
Axsome Therapeutics, Inc. · Chief Operating Officer
Jacobson Mark L. is listed in filings as Chief Operating Officer at Axsome Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 5, 2026, including sale activity. Recent filings connect the profile to Axsome Therapeutics, Inc. (AXSM). The current snapshot covers public activity from Aug 9, 2024 to May 5, 2026. Reported amounts are shown as $3.0K to $1.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $1M4.5k shares | SellMay 4, 2026 | $227.94 | $224.71 | |
| $6M35.4k shares | SellFeb 26, 2026 | $161.88 | $224.71 | |
| $1M10k shares | SellSep 22, 2025 | $115.96 | $224.71 | |
| $5M40k shares | SellSep 16, 2025 | $114.23 | $224.71 | |
| $672k5.8k shares | SellSep 16, 2025 | $116.19 | $224.71 | |
| $3M25k shares | SellJun 9, 2025 | $110.44 | $224.71 | |
| $2M20k shares | SellMay 28, 2025 | $103.45 | $224.71 | |
| $2M20.7k shares | SellMay 27, 2025 | $104.66 | $224.71 | |
| $4M47.7k shares | SellAug 9, 2024 | $84.26 | $224.71 |